Product Images Atacand

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Atacand NDC 62559-642 by Ani Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Graph-1 - Graph 1

Graph-1 - Graph 1

This is a table listing several parameters related to patient data, such as age, sex, race, NYHA, LVEF, etc. The table also lists patients' medical history, including diabetes, hypertension, previous MI, etc. There are treatment options listed, such as ACE inhibitor, p-blocker, spironolactone, etc. The table categorizes the given data into "ATACAND better," "Placebo better," and "Patients (n)." Finally, the table presents "Hazard Ratios." Overall, this table seems to be a medical data summary that may be used for statistical analysis.*

Label-16mg - Label 16mg

Label-16mg - Label 16mg

This is a medication called Candestartan Cilexetil USP, with a strength of 16 mg per tablet. The recommended adult dosage is not given on this label, so it is important to review the accompanying prescribing information. The medication should be stored at room temperature and kept in a tightly closed container. The manufacturer is AstraZeneca AB, located in Sodertalje, Sweden. Candestartan Cilexetil is a trademark of AstraZeneca and is licensed to ANI Pharmaceuticals. The tablets are produced under a license from Takeda Pharmaceutical Company. Overall, this label provides important details regarding the medication's composition, storage and manufacturing.*

Label-32mg - Label 32mg

Label-32mg - Label 32mg

Each tablet of this medication, named ATACAND, contains 32mg of Candesartan Cilexetil. The usual adult dosage can be found in the accompanying prescribing information. It is recommended to store the medication between 20° to 25°C (68° to 77°F) in a tightly closed container. It is important to keep this and all medication out of reach from children. This medication is manufactured by AstraZeneca AB in Sweden and distributed by ANI Pharmaceuticals, Inc. The trademark ATACAND belongs to the AstraZeneca group and is licensed to ANI Pharmaceuticals, Inc. It is manufactured under the license from Takeda Pharmaceutical Company, Ltd. The label shows an NDC-62559-643-30 number and a LOT-A1234567890123 number.*

Label-4mg - Label 4mg

Label-4mg - Label 4mg

Each tablet contains 4mg of Candesartan Cilexetil USP. The recommended adult dosage is specified in the accompanying prescribing information. The product should be stored at controlled room temperature between 20° to 25°C (68° to 77°F). The medication should be kept out of reach of children, and the container must be tightly closed. The tablets are manufactured by AstraZeneca AB in Sweden and distributed by ANI Pharmaceuticals, Inc. The product is licensed to ANI Pharmaceuticals and is a trademark of the AstraZeneca group of companies. The tablets are manufactured under license from Takeda Pharmaceuticals. The product comes in a pack of 30 tablets.*

Label-8mg - Label 8mg

Label-8mg - Label 8mg

Each tablet of Atacand contains 8mg of Candesartan Cilexetil USP. The usual adult dosage should be consulted with the prescribing information. The medication should be stored in a temperature range of 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] and the container should be tightly closed. It's important to keep the medication out of reach of children. Atacand is a trademark of the AstraZeneca group of companies and is licensed to ANI Pharmaceuticals, Inc., manufactured under the license from Takeda Pharmaceutical Company, Ltd. The product is distributed by ANI Pharmaceuticals, Inc. The details of LOT and SN are not available.*

structural formula - image 01

structural formula - image 01

logo - logo 01

logo - logo 01

logo - logo

logo - logo

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.